Measurement of peroxiredoxin-4 serum levels in rat tissue and its use as a potential marker for hepatic disease

Molecular Medicine Reports

Volumn 6, Issue 2, 2012, Pages 379-384

  Ito, Ritsu ^a   Takahashi, Motoko ^b   Ihara, Hideyuki ^a   Tsukamoto, Hiroki ^a   Fujii, Junichi ^c   Ikeda, Yoshitaka ^a  

^a SAGA UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Liver; Long Evans Cinnamon rat; Oxidative stress; Peroxiredoxin

Indexed keywords

ACETYLCYSTEINE; PEROXIREDOXIN 4; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RABBIT; HEPATOMA CELL; IMMUNOASSAY; LIVER DISEASE; LONG EVANS CINNAMON RAT; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; STREPTOZOCIN DIABETES; TISSUE DISTRIBUTION; TISSUE LEVEL; WILSON DISEASE;

ACETYLCYSTEINE; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CULTURE MEDIA; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN G; LIVER; LIVER DISEASES; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIREDOXINS; RABBITS; RATS; RATS, INBRED LEC; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECOMBINANT PROTEINS; TUMOR MARKERS, BIOLOGICAL; VACCINATION;

CINNAMOMUM VERUM; MAMMALIA; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84863440271     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.935     Document Type: Article

References (38)

1. Halliwell B and Gutteridge JMC: Free Radicals in Biology and Medicine. 4th edition. Oxford University Press, Oxford, United Kingdom, 2007.
2. Fridovich I: Oxygen toxicity: a radical explanation. J Exp Biol 201: 1203-1209, 1998.
3. Papa S and Skulachev VP: Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 174: 305-319, 1997. (Pubitemid 27404207)
4. Rhee SG, Kang SW, Chang TS, Jeong W and Kim K: Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52: 35-41, 2001. (Pubitemid 33769667)
5. 2: regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid Redox Signal 7: 619-626, 2005.
6. Rhee SG, Chae HZ and Kim K: Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-5152, 2005.
7. Fujii J and Ikeda Y: Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 7: 123-130, 2002. (Pubitemid 34700435)
8. Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ and Shao ZM: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 9: R76, 2007.
9. Iraqui I, Faye G, Ragu S, Masurel-Heneman A, Kolodner RD and Huang ME: Human peroxiredoxin PrxI is an orthologue of yeast Tsa1, capable of suppressing genome instability in Saccharomyces cerevisiae. Cancer Res 68: 1055-1063, 2008. (Pubitemid 351272223)
10. Song IS, Kim SU, Oh NS, Kim J, Yu DY, Huang SM, Kim JM, Lee DS and Kim NS: Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Carcinogenesis 30: 1106-1114, 2009.
11. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH and Van Etten RA: Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424: 561-565, 2003. (Pubitemid 36975778)
12. Fang J, Nakamura T, Cho DH, Gu Z and Lipton SA: S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci USA 104: 18742-18747, 2007. (Pubitemid 350210767)
13. Cha MK, Suh KH and Kim IH: Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J Exp Clin Cancer Res 28: 93, 2009.
14. Karihtala P, Mantyniemi A, Kang SW, Kinnula VL and Soini Y: Peroxiredoxins in breast carcinoma. Clin Cancer Res 9: 3418-3424, 2003. (Pubitemid 37082738)
15. Quan C, Cha EJ, Lee HL, Han KH, Lee KM and Kim WJ: Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer. J Urol 175: 1512-1516, 2006.
16. Lehtonen ST, Svensk AM, Soini Y, Paakko P, Hirvikoski P, Kang SW, Saily M and Kinnula VL: Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 111: 514-521, 2004. (Pubitemid 39045317)
17. Yanagawa T, Iwasa S, Ishii T, Tabuchi K, Yusa H, Onizawa K, Omura K, Harada H, Suzuki H and Yoshida H: Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett 156: 27-35, 2000. (Pubitemid 30326764)
18. Chang JW, Jeon HB, Lee JH, Yoo JS, Chun JS, Kim JH and Yoo YJ: Augmented expression of peroxiredoxin I in lung cancer. Biochem Biophys Res Commun 289: 507-512, 2001. (Pubitemid 33141083)
19. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS and Woo HA: Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 17: 183-189, 2005. (Pubitemid 40380942)
20. 2, a necessary evil for cell signaling. Science 312: 1882-1883, 2006.
21. Okado-Matsumoto A, Matsumoto A, Fujii J and Taniguchi N: Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem 127: 493-501, 2000. (Pubitemid 30185255)
22. Tavender TJ, Sheppard AM and Bulleid NJ: Peroxiredoxin IV is an endoplasmic reticulum-localized enzyme forming oligomeric complexes in human cells. Biochem J 411: 191-199, 2008. (Pubitemid 351482361)
23. Schulte J, Struck J, Bergmann A and Kohrle J: Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum. Clin Chim Acta 411: 1258-1263, 2010.
24. 2 produced during disulphide formation. J Cell Sci 123: 2672-2679, 2010.
25. Bertolotti M, Yim SH, Garcia-Manteiga JM, Masciarelli S, Kim YJ, Kang MH, Iuchi Y, Fujii J, Vene R, Rubartelli A, Rhee SG and Sitia R: B- to plasma-cell terminal differentiation entails oxidative stress and profound reshaping of the antioxidant responses. Antioxid Redox Signal 13: 1133-1144, 2010.
26. Ikeda Y, Ito R, Ihara H, Okada T and Fujii J: Expression of N-terminally truncated forms of rat peroxiredoxin-4 in insect cells. Protein Expr Purif 72: 1-7, 2010.
27. Matsumoto A, Okado A, Fujii T, Fujii J, Egashira M, Niikawa N and Taniguchi N: Cloning of the peroxiredoxin gene family in rats and characterization of the fourth member. FEBS Lett 443: 246-250, 1999. (Pubitemid 29080804)
28. Yoshida MC, Masuda R, Sasaki M, Takeichi N, Kobayashi H, Dempo K and Mori M: New mutation causing hereditary hepatitis in the laboratory rat. J Hered 78: 361-365, 1987. (Pubitemid 18027888)
29. Li Y, Togashi Y, Sato S, Emoto T, Kang JH, Takeichi N, Kobayashi H, Kojima Y, Une Y and Uchino J: Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J Clin Invest 87: 1858-1861, 1991.
30. Wu J, Forbes JR, Chen HS and Cox DW: The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet 7: 541-545, 1994. (Pubitemid 24308344)
31. Masuda R, Yoshida MC, Sasaki M, Dempo K and Mori M: High susceptibility to hepatocellular carcinoma development in LEC rats with hereditary hepatitis. Jpn J Cancer Res 79: 828-835, 1988.
32. Marquez-Quinones A, Cipak A, Zarkovic K, Fattel-Fazenda S, Villa-Trevino S, Waeg G, Zarkovic N and Gueraud F: HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res 44: 119-127, 2010.
33. Samuele A, Mangiagalli A, Armentero MT, Fancellu R, Bazzini E, Vairetti M, Ferrigno A, Richelmi P, Nappi G and Blandini F: Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease. Biochim Biophys Acta 1741: 325-330, 2005. (Pubitemid 41338678)
34. Madhani M, Barchowsky A, Klei L, Ross CR, Jackson SK, Swartz HM and James PE: Antibacterial peptide PR-39 affects local nitric oxide and preserves tissue oxygenation in the liver during septic shock. Biochim Biophys Acta 1588: 232-240, 2002. (Pubitemid 35223467)
35. Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T, Takahashi S and Bannai S: Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem 280: 37423-37429, 2005. (Pubitemid 41642349)
36. 2 measurements by electron paramagnetic resonance oximetry: current status and future potential for experimental and clinical studies. Antioxid Redox Signal 9: 1169-1182, 2007.
37. Nagaoka Y, Iuchi, Y, Ikeda Y and Fujii J: Glutathione reductase is expressed at high levels in pancreatic islet cells. Redox Rep 9: 321-324, 2004. (Pubitemid 40185436)
38. Fujii T, Fujii J and Taniguchi N: Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role. Eur J Biochem 268: 218-225, 2001.